These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 19116508)

  • 21. Exploring cell-based tolerance strategies for hand and face transplantation.
    Fryer M; Grahammer J; Khalifian S; Furtmüller GJ; Lee WP; Raimondi G; Brandacher G
    Expert Rev Clin Immunol; 2015; 11(11):1189-204. PubMed ID: 26289376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tolerance induction via mixed chimerism in vascularized composite allotransplantation: is it time for clinical application?
    Cetrulo CL; Drijkoningen T; Sachs DH
    Curr Opin Organ Transplant; 2015 Dec; 20(6):602-7. PubMed ID: 26536420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunological tolerance and liver transplantation].
    Sánchez-Fueyo A
    Gastroenterol Hepatol; 2005 Apr; 28(4):250-6. PubMed ID: 15811269
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term acceptance of composite tissue allografts through mixed chimerism and CD28 blockade.
    Foster RD; Pham S; Li S; Aitouche A
    Transplantation; 2003 Sep; 76(6):988-94. PubMed ID: 14508367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Allopeptide-pulsed dendritic cells and composite tissue allograft survival.
    Nguyen VT; Taieb A; Sacks JM; Unadkat JV; Clavijo JA; Kim H; Feili-Hariri M; Lee WP
    Microsurgery; 2007; 27(2):105-11. PubMed ID: 17290380
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dendritic cells,tolerance and therapy of organ allograft rejection.
    Raimondi G; Thomson AW
    Contrib Nephrol; 2005; 146():105-120. PubMed ID: 15567925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alloantigen-pulsed host dendritic cells induce T-cell regulation and prolong allograft survival in a rat model of hindlimb allotransplantation.
    Kuo YR; Huang CW; Goto S; Wang CT; Hsu LW; Lin YC; Yang KD; Chen CL; Lee WP
    J Surg Res; 2009 May; 153(2):317-25. PubMed ID: 19101689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulation of CD45 antigen in transplantation tolerance.
    Ko S; Jaeger MD; Dahlke MH; Nakajima Y; Schlitt HJ
    Curr Mol Med; 2002 May; 2(3):249-55. PubMed ID: 12041728
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical strategy for induction of transplantation tolerance through mixed chimerism.
    Cosimi AB; Sachs DH; Sykes M; Kawai T
    Clin Transpl; 2013; ():127-34. PubMed ID: 25095501
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Composite tissue transplantation.
    Brandacher G
    Methods Mol Biol; 2013; 1034():103-15. PubMed ID: 23775733
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tolerogenic dendritic cells: applications for solid organ transplantation.
    Beriou G; Moreau A; Cuturi MC
    Curr Opin Organ Transplant; 2012 Feb; 17(1):42-7. PubMed ID: 22227722
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Donor-specific tolerance induction in composite tissue allografts.
    Foster RD; Fan L; Neipp M; Kaufman C; McCalmont T; Ascher N; Ildstad S; Anthony JP; Niepp M
    Am J Surg; 1998 Nov; 176(5):418-21. PubMed ID: 9874425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Composite vascularized skin/bone transplantation models for bone marrow-based tolerance studies.
    Ozmen S; Ulusal BG; Ulusal AE; Izycki D; Siemionow M
    Ann Plast Surg; 2006 Mar; 56(3):295-300. PubMed ID: 16508361
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impact of donor bone marrow on survival of composite tissue allografts.
    Siemionow M; Nasir S
    Ann Plast Surg; 2008 Apr; 60(4):455-62. PubMed ID: 18362579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Simultaneous blockade of co-stimulatory signals, CD28 and ICOS, induced a stable tolerance in rat heart transplantation.
    Guo L; Fujino M; Kimura H; Funeshima N; Kitazawa Y; Harihara Y; Tezuka K; Makuuchi M; Suzuki S; Li XK
    Transpl Immunol; 2003; 12(1):41-8. PubMed ID: 14551031
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The beginning of clinical tolerance in solid organ allografts.
    Monaco AP
    Exp Clin Transplant; 2004 Jun; 2(1):153-61. PubMed ID: 15859922
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Increased apoptosis of immunoreactive host cells and augmented donor leukocyte chimerism, not sustained inhibition of B7 molecule expression are associated with prolonged cardiac allograft survival in mice preconditioned with immature donor dendritic cells plus anti-CD40L mAb.
    Lu L; Li W; Zhong C; Qian S; Fung JJ; Thomson AW; Starzl TE
    Transplantation; 1999 Sep; 68(6):747-57. PubMed ID: 10515374
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Donor and recipient leukocytes in organ allografts of recipients with variable donor-specific tolerance: with particular reference to chronic rejection.
    Ichikawa N; Demetris AJ; Starzl TE; Ye Q; Okuda T; Chun HJ; Liu K; Kim YM; Murase N
    Liver Transpl; 2000 Nov; 6(6):686-702. PubMed ID: 11084053
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chimerism induction in vascularized bone marrow transplants augmented with bone marrow cells.
    Arslan E; Klimczak A; Siemionow M
    Microsurgery; 2007; 27(3):190-9. PubMed ID: 17326192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance-inducing immunosuppressive strategies in clinical transplantation: an overview.
    Golshayan D; Pascual M
    Drugs; 2008; 68(15):2113-30. PubMed ID: 18840003
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.